Specialist boutiques have emerged as primary liquidity engines for European innovation, typically focusing on transactions valued between $25 Million and $250 Million. Unlike traditional banks staffed by career financiers, founder-bankers possess direct operational experience derived from having personally built, scaled and exited clinical technology enterprises. This practitioner-led background is central to their advisory positioning, enabling them to translate early-stage